http://www.acc.org/Feed?clinicalTopicID=0b213bea-9a50-4a88-aa7f-678a7be1de93 Clinical Topic Feed: Vascular Medicine en /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1785581280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/29/13/18/eagles-eye-view-29jul2026 In this week’s View, Dr. Eagle looks at a post-hoc analysis of the API-CAT trial that showed recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival of patients with cancer-associated thrombosis. 1785331140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/28/17/19/Indexing-Ascending-Aortic-Dimensions Indexing ascending aortopathy (AA) to height better identifies patients, especially women, who could benefit from earlier surgery rather than absolute diameters, according to a recent study published in JACC: Advances. 1785325260000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/20/14/38/API-CAT-Analysis Recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival among patients with cancer-associated thrombosis on extended apixaban therapy after at least six months of anticoagulation treatment, according to a post-hoc analysis of the API-CAT trial published July 13 in Circulation. 1784571060000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/02/15/04/Antihypertensive-Medications-in-Pregnancy-and-Lactation Effective management of hypertensive disorders of pregnancy is critical to reducing maternal morbidity, improving fetal outcomes, and mitigating long-term cardiovascular risk. This review provides a practical framework for antihypertensive medication selection in pregnancy and the postpartum period. 1783365540000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/29/15/28/Poll-Results-Brainstorm This poll included a clinical vignette of an 80-year-old man with atrial fibrillation (AF), high thromboembolic risk, and multiple cardiovascular (CV) comorbidities who presented 2 months after a spontaneous lobar intracerebral hemorrhage while receiving reduced-dose apixaban... 1782913920000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/01/Peripheral-Matters Until the ACC/AHA guideline on the management of acute pulmonary embolism (PE) was published in February, more than a decade had passed since the last one. During this interval, catheter-based interventions have expanded substantially, reshaping management of intermediate-risk PE. 1782908220000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1782907740000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/Patients-With-Reduced-LVEF-Undergoing-LAAO There was no significant difference in procedural success, major in-hospital complications or stroke at one year in patients undergoing transcatheter left atrial appendage occlusion (LAAO) with reduced LVEF; however, these patients did exhibit higher mortality at one year... 1782845400000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/24/22/05/New-Risk-Score The novel ONCO-DOAC BLEED risk score, developed by Tomoyuki Nagai, MD, et al., provided clinically relevant major bleeding risk stratification for patients with cancer-associated venous thromboembolism (VTE) receiving direct oral anticoagulants (DOAC), according to research published June 16 in JACC: CardioOncology. 1782407460000 Articles and Stories